XEVROS Trademark
Trademark Overview
On Monday, January 29, 2024, a trademark application was filed for XEVROS with the United States Patent and Trademark Office. The USPTO has given the XEVROS trademark a serial number of 98380307. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 13, 2024. This trademark is owned by GLAXO GROUP LIMITED. The XEVROS trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases
General Information
| Serial Number | 98380307 |
| Word Mark | XEVROS |
| Filing Date | Monday, January 29, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, November 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | GLAXO GROUP LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Monday, January 29, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 14, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, August 14, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 14, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 14, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, August 16, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 7, 2024 | ASSIGNED TO LIE |
| Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
